Vaniqa (Eflornithine)
Purpose of Medication and Method of Action
Vaniqa is indicated for the reduction of excess facial hair in women. The efficacy of Vaniqa has only been studied on the face and area under the chin. It acts by inhibiting the enzyme, ornithine decarboxylase, an enzyme necessary for the synthesis and rate of growth of hair. Marked improvement should be visible after 8 weeks of treatment. Continued therapy is required to prevent hair regrowth.
Side Effects
Side effects include: transient stinging or redness on applied area. Do not apply to abraded areas of the skin.
Drug Interactions
None reported
Cautions and Contraindications
None
Usual Dose
Apply thin layer to area and rub in thoroughly. Do not wash area for at least 4 hours. Use twice daily at least 8 hours apart. You should continue to use other hair removal techniques as needed in conjunction with Vaniqa being applied at least 5 minutes after hair removal. Cosmetics or sunscreen may be applied over the treated areas after the area has dried.
Patient Medication Information
These information sheets do not list all known side effects of the medications, only the most common side effects. For a complete list of side effects please contact your local pharmacy or the actual drug manufacturing company.